Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Inglis

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Transfusion|May 1, 1985
Mouse monoclonal antibodies reacting with M blood group-related antigensR H Fraser, G Inglis, A Mackie, et al.
Journal of Viral Hepatitis|August 20, 2005
Polymorphisms of the renin-angiotensin system and the severity of fibrosis in chronic hepatitis C virus infectionE H Forrest, D Thorburn, E Spence, et al.
BMC Health Services Research|April 9, 2022
Access to health care for people with stroke in South Africa: a qualitative study of community perspectivesT Smythe, G Inglis-Jassiem, T Conradie, et al.
Journal of Hypertension|December 1, 1985
A study of the renin inhibitor H142 in manD J Webb, P J Manhem, S G Ball, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Clinical and biochemical effects of the renin inhibitor H142 in humansD J Webb, P J Manhem, S G Ball, et al.
Journal of Medicinal Chemistry|November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitorsC Chan, E J Bailey, C D Hartley, et al.
Environmental Toxicology and Chemistry|July 4, 2019
Mode of Action Classifications in the EnviroTox Database: Development and Implementation of a Consensus MOA ClassificationAude Kienzler, Kristin A Connors, Mark Bonnell, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase--GW311616A a development candidateS J Macdonald, M D Dowle, L A Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactamsS J Macdonald, M D Dowle, L A Harrison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
Post-TB health and wellbeingR Nightingale, F Carlin, J Meghji, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Transfusion|May 1, 1985
Mouse monoclonal antibodies reacting with M blood group-related antigensR H Fraser, G Inglis, A Mackie, et al.
Journal of Viral Hepatitis|August 20, 2005
Polymorphisms of the renin-angiotensin system and the severity of fibrosis in chronic hepatitis C virus infectionE H Forrest, D Thorburn, E Spence, et al.
BMC Health Services Research|April 9, 2022
Access to health care for people with stroke in South Africa: a qualitative study of community perspectivesT Smythe, G Inglis-Jassiem, T Conradie, et al.
Journal of Hypertension|December 1, 1985
A study of the renin inhibitor H142 in manD J Webb, P J Manhem, S G Ball, et al.
Journal of Cardiovascular Pharmacology|January 1, 1987
Clinical and biochemical effects of the renin inhibitor H142 in humansD J Webb, P J Manhem, S G Ball, et al.
Journal of Medicinal Chemistry|November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitorsC Chan, E J Bailey, C D Hartley, et al.
Environmental Toxicology and Chemistry|July 4, 2019
Mode of Action Classifications in the EnviroTox Database: Development and Implementation of a Consensus MOA ClassificationAude Kienzler, Kristin A Connors, Mark Bonnell, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2001
The discovery of a potent, intracellular, orally bioavailable, long duration inhibitor of human neutrophil elastase--GW311616A a development candidateS J Macdonald, M D Dowle, L A Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactamsS J Macdonald, M D Dowle, L A Harrison, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 10, 2023
Post-TB health and wellbeingR Nightingale, F Carlin, J Meghji, et al.
Pageof 7